Management of hypothyroidism by Kshara Basti (therapeutic enema)- A case report.

Ayu Pub Date : 2019-10-01 Epub Date: 2021-01-14 DOI:10.4103/ayu.AYU_297_18
Karishma Singh, Adil Rais, Anup B Thakar
{"title":"Management of hypothyroidism by <i>Kshara Basti</i> (therapeutic enema)- A case report.","authors":"Karishma Singh,&nbsp;Adil Rais,&nbsp;Anup B Thakar","doi":"10.4103/ayu.AYU_297_18","DOIUrl":null,"url":null,"abstract":"<p><p>Hypothyroidism is emerging as a common health concern in India as well as worldwide. An autoimmune cause accounts for approximately 90% of adult hypothyroidism mostly due to Hashimoto's disease. This autoimmunity goes parallel with the theory of <i>Ama</i> (intermediatory product) in Ayurveda. A case of a 27-year-old female patient, presenting with pain in multiple joints, deformity in the right little finger, morning stiffness lasting for more than 3 h, reduced appetite, constipation, and lethargy, diagnosed with <i>Amavata</i> (rheumatoid arthritis), was subclinically diagnosed with hypothyroidism and treated with <i>Deepana</i> (stimulates digestion), <i>Pachana</i> (promots digestion) and <i>Koshtha</i> <i>Shuddhi</i> (mild purgation) for 5 days followed by <i>Kshara</i> <i>Basti</i> (therapeutic enema) for 5 days. Reduction in serum- thyroid-stimulating hormone (S. TSH) (31.1 mIU/ml to 16.6 mIU/ml) along with relief in clinical manifestations of the disease was the outcome. <i>Koshtha</i> <i>Shuddhi</i> followed by <i>Kshara</i> <i>Basti</i> has its efficacy in hypothyroidism, as it not only improved signs and symptoms but S.TSH level was reduced significantly. This case report proposes an innovative treatment modality for the management of hypothyroidism, which needs to be validated through a well-planned study on a large sample size.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":"40 4","pages":"237-241"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1a/df/AYU-40-237.PMC8078602.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ayu","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ayu.AYU_297_18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/14 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Hypothyroidism is emerging as a common health concern in India as well as worldwide. An autoimmune cause accounts for approximately 90% of adult hypothyroidism mostly due to Hashimoto's disease. This autoimmunity goes parallel with the theory of Ama (intermediatory product) in Ayurveda. A case of a 27-year-old female patient, presenting with pain in multiple joints, deformity in the right little finger, morning stiffness lasting for more than 3 h, reduced appetite, constipation, and lethargy, diagnosed with Amavata (rheumatoid arthritis), was subclinically diagnosed with hypothyroidism and treated with Deepana (stimulates digestion), Pachana (promots digestion) and Koshtha Shuddhi (mild purgation) for 5 days followed by Kshara Basti (therapeutic enema) for 5 days. Reduction in serum- thyroid-stimulating hormone (S. TSH) (31.1 mIU/ml to 16.6 mIU/ml) along with relief in clinical manifestations of the disease was the outcome. Koshtha Shuddhi followed by Kshara Basti has its efficacy in hypothyroidism, as it not only improved signs and symptoms but S.TSH level was reduced significantly. This case report proposes an innovative treatment modality for the management of hypothyroidism, which needs to be validated through a well-planned study on a large sample size.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
治疗性灌肠治疗甲状腺功能减退1例。
甲状腺功能减退症正在成为印度乃至全世界普遍关注的健康问题。自身免疫性疾病约占成人甲状腺功能减退的90%,主要由桥本氏病引起。这种自身免疫与阿育吠陀的Ama(中间产物)理论平行。1例27岁女性患者,以多关节疼痛,右小指畸形,晨僵持续3小时以上,食欲减退,便秘,嗜睡,诊断为Amavata(类风湿关节炎),亚临床诊断为甲状腺功能减退,分别用Deepana(刺激消化),Pachana(促进消化),Koshtha Shuddhi(轻度净化)治疗5天,Kshara Basti(治疗性灌肠)治疗5天。结果是血清促甲状腺激素(S. TSH)降低(31.1 mIU/ml至16.6 mIU/ml),同时疾病的临床表现得到缓解。kshtha Shuddhi继用Kshara Basti治疗甲状腺功能减退症,不仅改善了症状和体征,而且显著降低了S.TSH水平。本病例报告提出了一种治疗甲状腺功能减退的创新治疗方式,需要通过精心策划的大样本量研究来验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Ayu
Ayu
自引率
0.00%
发文量
0
期刊最新文献
A systematic review in health care: Need and significance. Ayurveda fundamentals and science - A perspective. Management of Mutrashmari (urolithiasis) with Palasha Kshara and Ashmarihara Kwatha: An open-labelled placebo-controlled clinical trial. A lexical review on Vishaghna Dravyas of Kaideva Nighantu. Antioxidant content and activity of stem and leaf extracts of Gouania longipetala Hemsl. (Rhamnaceae).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1